EBR:BCART • BE0974281132
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Biocartis Group NV (BCART.BR).
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 43.128M 15.18% | 48.269M 11.92% | 57.481M 19.08% | 59.74M 3.93% | 78.28M 31.03% | 103M 31.58% | |
| EBITDA YoY % growth | -37.114M 19.11% | -52.8M -42.26% | -36.566M 30.75% | -26.78M 26.76% | -6.18M 76.92% | 9.27M 250.00% | |
| EBIT YoY % growth | -46.862M 15.72% | -62.645M -33.68% | -47.047M 24.90% | -36.05M 23.37% | -18.54M 48.57% | 4.12M 122.22% | |
| Operating Margin | -108.66% | -129.78% | -81.85% | -60.34% | -23.68% | 4.00% | |
| EPS YoY % growth | N/A -1.36% | N/A -15.70% | N/A 55.57% | -0.33 36.00% | -0.13 59.38% | -0.04 69.23% |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
9 analysts have analysed BCART.BR and the average price target is 1.12 EUR. This implies a price increase of 286.9% is expected in the next year compared to the current price of 0.29.
The consensus rating for Biocartis Group NV (BCART.BR) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.